Research and Development

The search for a ‘silver bullet’ against cancer has failed, for now, with the battle against the disease turning instead …

Sanofi-Aventis is to collaborate on translational biomedical research with Harvard University in therapy areas such as cancer, diabetes and inflammation. …

Novartis has published new data at the annual meeting of the American Society for Bone and Mineral Research in Toronto …

Swiss drugmaker Roche is planning to invest $180 million and boost staff at its diagnostics subsidiary Ventana Medical Systems, as …

In 1906 a psychiatrist working in a Frankfurt asylum became fascinated by the unnamed illness suffered by one of his …

Our latest crop of contract research news includes updates from Clinipace, PPD, Cellectis bioresearch, Covance, Quintiles and Synexus. US contract …

Celgene has completed its acquisition of Abraxis BioScience for cash and stock totalling $2.9 billion. The takeover gives the cancer …

Researchers from Germany’s cost-effectiveness body IQWiG have unearthed a mountain of unpublished data from trials of Pfizer’s reboxetine that show …

Merck Serono has expanded its research with Ablynx and will co-develop ‘Nanobodies’ from the Belgian biotech against an inflammatory disease …

The government is to put more than £50 million of funding into a new initiative to produce more targeted research …

Shire has appointed Philip Vickers as senior VP of research and development for its Human Genetic Therapies (HGT) business. He …

Moscow-based pharmaceutical company JSC Pharmsynthez has appointed Miroslav Ravic and Howard Fisher to its board as independent non-executive directors. Miroslav …

UCB has partnered with Synosia Therapeutics to develop two of the Swiss firm’s compounds for Parkinson’s disease.  Basel-based Synosia has …

Geron Corporation has enrolled the first patient in its restarted clinical trial of human embryonic stem cells (hESC). The world’s …

As the budgets of pharma companies face continued downward pressure, the objective of outsourcing is not only to find effective …